Effect of Piperacillin/Tazobactam Solution Concentration on the Infusion Rate of Portable Elastomeric Pumps (‘EMPs’) in Hospital in the Home: A Retrospective Review of Administered and Residual Volumes
The Journal of Advanced Home Medicine · 2026
DOI: 10.64919/001c.162479 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Advanced Home Medicine, 2026. Verfasst von Toni Docherty und 8 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Importance Piperacillin/tazobactam solutions are frequently administered as 24-hour continuous intravenous infusions to patients in Hospital in the Home (HITH) programs and the accuracy of administration from elastomeric pumps (‘EMPs’) is important.
Objective
This study aimed to review the effect of piperacillin/tazobactam solution concentration on the rate of infusion from ‘EMPs’ to patients in the clinical HITH setting, by reviewing the volumes of residual and administered solution.
Design
This retrospective audit was conducted from 6/11/2021 to 14/6/2023 and the following information was collected for patients treated with piperacillin/tazobactam EMPs: patient details, treatment indication, EMP solution concentration, time of EMP attachment/detachment, volume of antibiotic solution remaining (if any), EMP type/brand, central line type, and central line issues (if any).
Setting
This study was conducted in the Central Coast Health District (CCLHD) HITH in New South Wales, Australia.
Participants
Patients treated with 24-hour continuous intravenous infusions of piperacillin/tazobactam via EMPs on the CCLHD HITH service.
Results
For all EMPs over all times, a median residual volume of 30mL (IQR: 0-50mL) was recorded (n=2152). Piperacillin/tazobactam 75mg/mL (18g/240mL) EMPs had a median residual volume of 50mL (IQR 20-70mL) when removed at ‘all times’ (n=170) and ‘=24 hours’ (n=184). Residual volumes >15% occurred 48% of the time when removed ‘=24 hours’ (n=325). Piperacillin/tazobactam 75mg/mL (18g/240mL) EMPs were significantly less likely to be removed (at ≥24 hours) with ≤15% residual volume compared to the piperacillin/tazobactam 37.5mg/mL (9g/240mL; p
Zitieren
APA
Docherty, T., Schneider, J., Cooper, J., Robertson, M., Warren, E., Palmqvist, C., Pearce, J., Viljoen, M., & David, M. (2026). Effect of Piperacillin/Tazobactam Solution Concentration on the Infusion Rate of Portable Elastomeric Pumps (‘EMPs’) in Hospital in the Home: A Retrospective Review of Administered and Residual Volumes. The Journal of Advanced Home Medicine. https://doi.org/10.64919/001c.162479
Vancouver
Docherty T, Schneider J, Cooper J, Robertson M, Warren E, Palmqvist C, et al. Effect of Piperacillin/Tazobactam Solution Concentration on the Infusion Rate of Portable Elastomeric Pumps (‘EMPs’) in Hospital in the Home: A Retrospective Review of Administered and Residual Volumes. The Journal of Advanced Home Medicine. 2026. doi:10.64919/001c.162479
BibTeX
@article{Docherty2026,
author = {Docherty, Toni and Schneider, Jenny and Cooper, Joyce and Robertson, Mark and Warren, Eloise and Palmqvist, Catherine and Pearce, Jessica and Viljoen, Marte and David, Michael},
title = {Effect of Piperacillin/Tazobactam Solution Concentration on the Infusion Rate of Portable Elastomeric Pumps (‘EMPs’) in Hospital in the Home: A Retrospective Review of Administered and Residual Volumes},
journal = {The Journal of Advanced Home Medicine},
year = {2026},
doi = {10.64919/001c.162479}
}
EUVIMED